Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18549648rdf:typepubmed:Citationlld:pubmed
pubmed-article:18549648lifeskim:mentionsumls-concept:C0003315lld:lifeskim
pubmed-article:18549648lifeskim:mentionsumls-concept:C0039194lld:lifeskim
pubmed-article:18549648lifeskim:mentionsumls-concept:C0205369lld:lifeskim
pubmed-article:18549648lifeskim:mentionsumls-concept:C0439855lld:lifeskim
pubmed-article:18549648lifeskim:mentionsumls-concept:C1533691lld:lifeskim
pubmed-article:18549648lifeskim:mentionsumls-concept:C0205263lld:lifeskim
pubmed-article:18549648lifeskim:mentionsumls-concept:C0039115lld:lifeskim
pubmed-article:18549648lifeskim:mentionsumls-concept:C1879547lld:lifeskim
pubmed-article:18549648pubmed:issue3lld:pubmed
pubmed-article:18549648pubmed:dateCreated2008-6-13lld:pubmed
pubmed-article:18549648pubmed:abstractTextThis study was aimed to investigate the effect of artificial antigen-presenting cells (aAPCs) on inducing activation and proliferation of specific T-lymphocytes through stimulating biological function of dendritic cells with aAPCs in vitro. The specific antigen of chronic myeloid leukemia CML-28 was screened as objective antigen peptide by using magnetic microbeads as vector; the CML-28 epitope sequence (Vltfaldsv) was obtained by antigen epitope prediction software; this epitope was coupled with MHC molecule and used as first signal molecule, the B7-1 molecule was used as second signal molecule; these 2 molecules simultaneously were loaded onto surface of magnetic microbeads so as to contract aAPC complex. The bone marrow mononuclear cells were derived from HLA-A2(+) healthy bone marrow donors, CD8(+) T lymphocytes were screened and co-cultured with aAPC complex. During culture the 5, 6-carboxyfluorescein diacetate succinimidyl ester (CFSE) was added and proliferation of T-lymphocytes was detected by CPSE and proliferation level of specific T lymphocytes was detected by flow cytometry. The results showed that the proliferation level of CML-28 specific T lymphocytes obviously increased in experimental group, average level was 17.34 +/- 0.65%, while average level in control was 2.25 +/- 0.43%, there was significant difference between them (p < 0.01). It is concluded that the aAPC complex can mimic human APCs in vitro, and stimulate activation and proliferation of CD8(+) specific T lymphocytes.lld:pubmed
pubmed-article:18549648pubmed:languagechilld:pubmed
pubmed-article:18549648pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18549648pubmed:citationSubsetIMlld:pubmed
pubmed-article:18549648pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18549648pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18549648pubmed:statusMEDLINElld:pubmed
pubmed-article:18549648pubmed:monthJunlld:pubmed
pubmed-article:18549648pubmed:issn1009-2137lld:pubmed
pubmed-article:18549648pubmed:authorpubmed-author:HuangWeiWlld:pubmed
pubmed-article:18549648pubmed:authorpubmed-author:LiuWen-LiWLlld:pubmed
pubmed-article:18549648pubmed:authorpubmed-author:ZhouJian-Feng...lld:pubmed
pubmed-article:18549648pubmed:authorpubmed-author:GengZheZlld:pubmed
pubmed-article:18549648pubmed:authorpubmed-author:MaoHan-WenHWlld:pubmed
pubmed-article:18549648pubmed:issnTypePrintlld:pubmed
pubmed-article:18549648pubmed:volume16lld:pubmed
pubmed-article:18549648pubmed:ownerNLMlld:pubmed
pubmed-article:18549648pubmed:authorsCompleteYlld:pubmed
pubmed-article:18549648pubmed:pagination655-8lld:pubmed
pubmed-article:18549648pubmed:meshHeadingpubmed-meshheading:18549648...lld:pubmed
pubmed-article:18549648pubmed:meshHeadingpubmed-meshheading:18549648...lld:pubmed
pubmed-article:18549648pubmed:meshHeadingpubmed-meshheading:18549648...lld:pubmed
pubmed-article:18549648pubmed:meshHeadingpubmed-meshheading:18549648...lld:pubmed
pubmed-article:18549648pubmed:meshHeadingpubmed-meshheading:18549648...lld:pubmed
pubmed-article:18549648pubmed:meshHeadingpubmed-meshheading:18549648...lld:pubmed
pubmed-article:18549648pubmed:meshHeadingpubmed-meshheading:18549648...lld:pubmed
pubmed-article:18549648pubmed:meshHeadingpubmed-meshheading:18549648...lld:pubmed
pubmed-article:18549648pubmed:meshHeadingpubmed-meshheading:18549648...lld:pubmed
pubmed-article:18549648pubmed:meshHeadingpubmed-meshheading:18549648...lld:pubmed
pubmed-article:18549648pubmed:meshHeadingpubmed-meshheading:18549648...lld:pubmed
pubmed-article:18549648pubmed:meshHeadingpubmed-meshheading:18549648...lld:pubmed
pubmed-article:18549648pubmed:meshHeadingpubmed-meshheading:18549648...lld:pubmed
pubmed-article:18549648pubmed:meshHeadingpubmed-meshheading:18549648...lld:pubmed
pubmed-article:18549648pubmed:meshHeadingpubmed-meshheading:18549648...lld:pubmed
pubmed-article:18549648pubmed:meshHeadingpubmed-meshheading:18549648...lld:pubmed
pubmed-article:18549648pubmed:year2008lld:pubmed
pubmed-article:18549648pubmed:articleTitle[Activation of specific T lymphocyte induced by artificial antigen presenting cell complex in vitro].lld:pubmed
pubmed-article:18549648pubmed:affiliationDeparment of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, Hubei Province, China. MHW555@21CN.COMlld:pubmed
pubmed-article:18549648pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:18549648pubmed:publicationTypeEnglish Abstractlld:pubmed
pubmed-article:18549648pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed